urografin-76 and Arterial-Occlusive-Diseases

urografin-76 has been researched along with Arterial-Occlusive-Diseases* in 2 studies

Trials

1 trial(s) available for urografin-76 and Arterial-Occlusive-Diseases

ArticleYear
A comparison of hexabrix and Renografin 60 in peripheral arteriography.
    AJR. American journal of roentgenology, 1983, Volume: 140, Issue:5

    Fifty-one patients were analyzed after a randomized double-blind study comparing Hexabrix and Renografin 60 in peripheral arteriography. The arteriographic studies and the volumes of contrast material used in both groups were similar. Hexabrix caused significantly less pain and discomfort than Renografin 60, and the diagnostic quality of the radiographs was comparable. A slightly higher incidence of minor side effects was noted in the Hexabrix group, mostly nausea and vomiting and urinary retention.

    Topics: Angiography; Arterial Occlusive Diseases; Contrast Media; Diatrizoate; Diatrizoate Meglumine; Double-Blind Method; Drug Combinations; Female; Humans; Iodobenzoates; Ioxaglic Acid; Male; Pain; Random Allocation; Triiodobenzoic Acids

1983

Other Studies

1 other study(ies) available for urografin-76 and Arterial-Occlusive-Diseases

ArticleYear
Differential effects of Renografin-76 on the ischemic and nonischemic myocardium.
    The American journal of cardiology, 1981, Volume: 47, Issue:3

    The effects of intracoronary diatrizoate meglumine and diatrizoate sodium (Renografin-76) on regional contraction were examined in the normal coronary circulation and during partial (50 percent) coronary occlusion in 11 dogs using strain and length gauges. Intracoronary injections of Renografin-76 (1.5 cc) (1.690 mosM/liter; 0.19 mEq Na/ml), equiosmolar dextrose solution and 0.19 mEq Na+/ml saline solution were made randomly. Renografin-76 caused a decrease in preejection tension to 87.4 +/- 4.3 percent (p less than 0.025), total tension to 74.6 +/- 3.3 percent (p less than 0.01) and ejection tension to 11.9 +/- 12.6 percent (p less than 0.001) of control value. Segment length increased to 106.7 +/- 7.3 percent of control value. These changes lasted only 12 +/- 2 (range 5 to 20) seconds (mean +/- standard error of the mean). During partial coronary occlusion and after injection of Renografin-76, preejection tension decreased from 91.7 +/- 6.3 to 53.8 +/- 3.9 percent (p less than 0.01), total tension from 89.9 +/- 5.0 to 59.7 +/- 3.5 percent (p less than 0.01) and ejection tension from 22.8 +/- 8.1 to 17.8 +/- 10.9 percent, whereas segment length increased from 112.7 +/- 3.7 to 130.7 +/- 4.6 percent (p less than 0.01) of control value. In contrast to findings in the normal coronary circulation, tension and length changes lasted 54 +/- 16 (range 15 to 180) seconds (p less than 0.05). The hyperemic response during normal coronary circulation was completely abolished during partial coronary occlusion. Prior administration of nitroglycerin did not shorten the duration of the myocardial depressant effects of Renografin. Injections of equiosmolar dextrose or saline solution produced qualitatively similar but quantitatively less marked changes. Thus, intracoronary Renografin-76 has an accentuated and prolonged depressant effect on the ischemic as compared with the normally perfused myocardium; this effect is not solely due to its hyperosmolarity or sodium concentration.

    Topics: Animals; Arterial Occlusive Diseases; Blood Pressure; Coronary Disease; Coronary Vessels; Diatrizoate; Diatrizoate Meglumine; Dogs; Drug Combinations; Glucose; Heart; Heart Rate; Nitroglycerin; Sodium Chloride

1981